22.28
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Corcept Therapeutics Inc | CORT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 22.28 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 22.28 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 16.86 | 27.78 | 10.92 | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 22.28 | USD |
Corcept Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.59B | 116.17M | 88.97M | $ 306.49M | $ 91.46M | 0.78 | 31.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Corcept Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CORT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.19 | 24.27 | 22.12 | 22.79 | 518,613 | -1.91 | -7.9% |
| 1 Month | 25.45 | 26.16 | 22.12 | 24.06 | 506,315 | -3.17 | -12.46% |
| 3 Months | 29.00 | 31.18 | 22.12 | 26.25 | 573,904 | -6.72 | -23.17% |
| 6 Months | 18.75 | 31.18 | 16.52 | 23.63 | 756,276 | 3.53 | 18.83% |
| 1 Year | 12.25 | 31.18 | 11.57 | 19.14 | 1,337,081 | 10.03 | 81.88% |
| 3 Years | 17.00 | 31.18 | 9.14 | 15.63 | 1,169,387 | 5.28 | 31.06% |
| 5 Years | 4.87 | 31.18 | 4.60 | 15.21 | 1,099,229 | 17.41 | 357.49% |
Corcept Therapeutics Description
| Corcept Therapeutics Inc is engaged in the discovery, development, and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol. |
